Broker tips: GlaxoSmithKline, AstraZeneca, Housebuilders
18th Jul 2014 12:23
Panmure Gordon said it is "not expecting fireworks" from GlaxoSmithKline's (GSK) second-quarter results due out next Wednesday. "In light of our recent downgrade to forecasts due to exchange rate headwinds, we are expecting another tough quarter. China has not washed through completely either and g
Read morePanmure "not expecting fireworks" from Glaxo's Q2 results
18th Jul 2014 12:22
Panmure Gordon is "not expecting fireworks" from GlaxoSmithKline's (GSK) second-quarter results due next Wednesday. "In light of our recent downgrade to forecasts due to exchange rate headwinds, we are expecting another tough quarter," said Analyst Savvas Neophytou. "China has not washed through c
Read moreGSK prosecutors "may examine earlier China bribery scandals"
17th Jul 2014 07:54
GlaxoSmithKline has allegedly admitted it found that staff were bribing Chinese officials and taking kickbacks as far back as 2001, according to the Financial Times. According to unidentified sources cited by the paper, GSK arranged for advisor PwC to investigate the potential corrupt practices an
Read moreGSK and Theravance begin late-stage test for COPD treatment
16th Jul 2014 10:32
GlaxoSmithKline has begun Phase III testing on a combined treatment for chronic obstructive pulmonary disease (COPD) with its US project partner Theravance. The global study is the first to evaluate the efficacy and safety of a triple combination of three drugs in 10,000 patients with COPD, all in
Read moreFX round-up: German and Portuguese concern weighs on euro
16th Jul 2014 09:19
Continuing weaker data from Germany and banking concerns from Portugal saw the euro weaken against the dollar on Tuesday, as US central banking chief Janet Yellen was slightly more optimistic on the economy. Germany's ZEW index of investor and analyst expectations, which aims to predict economic de
Read moreChina charges investigators linked to GSK
14th Jul 2014 13:43
Two foreign investigators linked to pharmaceutical giant GlaxoSmithKline (GSK) have been charged by prosecutors in Shanghai. Peter Humphrey, who was hired by GSK to find out who had been sending explicit videos of his China boss, and his wife, have been charged with "illegally obtaining private inf
Read moreMonday broker round-up UPDATE
14th Jul 2014 10:11
Abcam: Numis cuts target price from 510p to 490p and stays with its add rating. ARM Holdings: Credit Suisse reduces target price from 1200p to 1125p and maintains an outperform rating. AstraZeneca: Jefferies reduces target price from 4850p to 4790p maintaining a hold recommendation. BP: Credit Su
Read moreSunday newspaper round-up: Experian, Sports Direct, Shire
13th Jul 2014 12:24
Sir John Peace will suffer his third shareholder rebellion in three months this week when investors in Experian revolt over pay and succession plans at the credit checking company, the Sunday Times said. Peace will then have suffered rebellions at each of the three FTSE 100 companies he chairs. At B
Read moreWoodford reveals top 10 holdings dominated by pharma and tobacco
8th Jul 2014 13:21
Highly influential fund manager Neil Woodford has revealed the top 10 stocks in his new £1.6bn Woodford Equity Income fund, including new favourites Imperial Innovations and Rolls-Royce. The university technology spin-out group and the aircraft engine-maker did not feature in the manager's previous
Read moreSunday newspaper round-up: Shire, Mothercare, Blinkx, Barclays
6th Jul 2014 17:18
AbbVie is expected to make an improved offer for Shire in the next few days after its Chief Executive Rick Gonzalez visited Shire's biggest investors in London, The Sunday Times said. Gonzalez is back in the US mulling his options after having three bid approaches turned down with the most recent va
Read moreFriday newspaper round-up: House prices, Sports Direct, GlaxoSmithKline...
4th Jul 2014 07:36
The risk posed by surging house prices has now spread beyond London but intervening by raising interest rates remains a last resort, Bank of England deputy governor for financial stability Jon Cunliffe said yesterday. Cunliffe stressed that although the central bank cannot control house prices it ca
Read moreeg solutions Chief trades in 1.21m shares
2nd Jul 2014 16:11
Elizabeth Gooch, the acting Chief Executive Officer of eg solutions has traded in a total of 1.21m shares at 52p each, the software company said on Wednesday. Of these, 120,000 were acquired by the company's former Chairman, Rodney Baker-Bates, and a further 60,000 by Mark Brady, a non-executive d
Read moreWednesday broker round-up UPDATE
2nd Jul 2014 09:38
Anite: Investec places its target price (prev.: 88p) under review, while its hold recommendation remains unchanged. Ashcourt Rowan: N+1 Singer moves target price from 231p to 242p and keeps a buy recommendation. BG Group: Canaccord Genuity raises target price from 1250p to 1450p upgrading from hol
Read moreGlaxo submits new drug application for asthma treatment
30th Jun 2014 15:06
GlaxoSmithKline (GSK) on Monday announced that in partnership with US-listed Theravance it has submitted a supplemental new drug application (sNDA) to the US Food and Drug Administration (FDA) for two different doses of an asthma treatment taken through its Ellipta dry powder inhaler. The filing o
Read moreSunday newspaper round-up: Bank Rate, State pensions, Baghdad
29th Jun 2014 18:07
Over the longer-term, say five to ten years, it would be reasonable to expect borrowing costs to rise back to their pre-recesssion levels, of about 5%, but "it's probably quite a long way down the road" outgoing Bank of England Deputy Charlie Bean told Sky News in an interview. That comes after Gove
Read more